News & Articles

Avacta appoints BBI Solutions as manufacturing partner for the rapid SARS-CoV-2 antigen test being developed with Cytiva

Vanderbilt researchers use high-throughput data collection, analysis, and visualization to help understand synergy in therapeutic antibody cocktails

BLENREP is the fifth major medicine approval for GSK in 2020

With this numerical result expressed as index value, clinicians will be better equipped to evaluate the duration and level of an individual’s immune response

Exclusive interviews, new methods, free downloads, and much more to help you advance your work

California Laboratories can now instantly transmit covid-19 data to the CalREDIE system

Rapid antibody test receives CE mark for use by healthcare professionals

University of California San Francisco (UCSF) uses Phenoptics™ platform to help with biomarker discovery

TrueBinding signs multi-product commercial-use license to develop stable, antibody-expressing cell lines using Horizon’s gene-edited CHO GS knockout platform

Developed with enhanced technology, this new assay provides high-quality staining with improved turnaround time

The study is the first global, randomized, double-blind, placebo-controlled phase III trial investigating Actemra/RoActemra in this setting

Find out how LC-MS technology is being used to quantify the experimental drug remdesivir

The ViroKey™ SARS-CoV-2 RT-PCR Test v2.0 is a probe-based reverse transcription PCR test

Based on the results, the U.S.-based trial has been stopped, including in a second cohort of patients who received a higher dose of Kevzara (800 mg)

Partnerships, products, and solutions facilitate detection, research, and vaccine development to combat the SARS-CoV-2 virus

The “triple antibody” test will provide health professionals with an accurate indication of the presence of IgA, IgM and IgG COVID-19 antibodies within 10 minutes

Establishing a broad range of remotely accessible COVID-19 assays including biochemical profiling for COVID-19 drug targets

Avacta to begin clinical validation of the high-throughput COVID-19 laboratory test in collaboration with the UK government CONDOR program